Goldman Sachs’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $35.6M | Buy |
2,863,860
+282,785
| +11% | +$3.8M | ﹤0.01% | 1863 |
|
|
2025
Q4 | $32.5M | Buy |
2,581,075
+120,861
| +5% | +$1.38M | ﹤0.01% | 1883 |
|
|
2025
Q3 | $24.6M | Buy |
2,460,214
+224,680
| +10% | +$2.02M | ﹤0.01% | 2058 |
|
|
2025
Q2 | $18.1M | Buy |
2,235,534
+1,298,345
| +139% | +$9.79M | ﹤0.01% | 2214 |
|
|
2025
Q1 | $7.85M | Sell |
937,189
-36,556
| -4% | -$305K | ﹤0.01% | 2919 |
|
|
2024
Q4 | $7.71M | Buy |
973,745
+119,946
| +14% | +$1.01M | ﹤0.01% | 3037 |
|
|
2024
Q3 | $7.1M | Sell |
853,799
-526,613
| -38% | -$4.12M | ﹤0.01% | 3039 |
|
|
2024
Q2 | $8.77M | Buy |
1,380,412
+687,926
| +99% | +$4.37M | ﹤0.01% | 2630 |
|
|
2024
Q1 | $4.2M | Buy |
692,486
+355,215
| +105% | +$2M | ﹤0.01% | 3260 |
|
|
2023
Q4 | $2.05M | Sell |
337,271
-777,682
| -70% | -$3.46M | ﹤0.01% | 3910 |
|
|
2023
Q3 | $4.71M | Buy |
1,114,953
+496,781
| +80% | +$1.85M | ﹤0.01% | 3036 |
|
|
2023
Q2 | $1.92M | Buy |
618,172
+17,770
| +3% | +$37.9K | ﹤0.01% | 3909 |
|
|
2023
Q1 | $835K | Sell |
600,402
-65,967
| -10% | -$131K | ﹤0.01% | 4508 |
|
|
2022
Q4 | $1.33M | Buy |
666,369
+51,989
| +8% | +$117K | ﹤0.01% | 4238 |
|
|
2022
Q3 | $1.24M | Sell |
614,380
-134,275
| -18% | -$376K | ﹤0.01% | 4367 |
|
|
2022
Q2 | $2.38M | Sell |
748,655
-35,427
| -5% | -$128K | ﹤0.01% | 3895 |
|
|
2022
Q1 | $3.27M | Sell |
784,082
-199,714
| -20% | -$884K | ﹤0.01% | 3766 |
|
|
2021
Q4 | $4.71M | Buy |
983,796
+43,166
| +5% | +$215K | ﹤0.01% | 3469 |
|
|
2021
Q3 | $5.02M | Buy |
940,630
+255,551
| +37% | +$1.29M | ﹤0.01% | 3362 |
|
|
2021
Q2 | $3.51M | Buy |
685,079
+268,175
| +64% | +$1.52M | ﹤0.01% | 3673 |
|
|
2021
Q1 | $2.81M | Sell |
416,904
-299,911
| -42% | -$1.66M | ﹤0.01% | 3650 |
|
|
2020
Q4 | $3.28M | Buy |
716,815
+383,859
| +115% | +$1.7M | ﹤0.01% | 3351 |
|
|
2020
Q3 | $1.29M | Buy |
332,956
+167,563
| +101% | +$717K | ﹤0.01% | 3896 |
|
|
2020
Q2 | $788K | Sell |
165,393
-350,394
| -68% | -$1.44M | ﹤0.01% | 4116 |
|
|
2020
Q1 | $1.79M | Buy |
515,787
+176,335
| +52% | +$747K | ﹤0.01% | 3378 |
|
|
2019
Q4 | $1.64M | Sell |
339,452
-21,183
| -6% | -$73.6K | ﹤0.01% | 3781 |
|
|
2019
Q3 | $1.05M | Buy |
360,635
+133,481
| +59% | +$466K | ﹤0.01% | 4001 |
|
|
2019
Q2 | $1.63M | Sell |
227,154
-111,680
| -33% | -$1.14M | ﹤0.01% | 3668 |
|
|
2019
Q1 | $4.8M | Sell |
338,834
-70,027
| -17% | -$926K | ﹤0.01% | 2996 |
|
|
2018
Q4 | $5.53M | Buy |
408,861
+131,686
| +48% | +$2.37M | ﹤0.01% | 2791 |
|
|
2018
Q3 | $6.15M | Buy |
277,175
+72,347
| +35% | +$1.52M | ﹤0.01% | 2825 |
|
|
2018
Q2 | $3.36M | Buy |
+204,828
| New | +$3.59M | ﹤0.01% | 3239 |
|
Other funds holding AMRX
TGA
VPM
RCMNY
VCM
